rs3213619

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001348946.2(ABCB1):​c.-129T>C variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0511 in 152,430 control chromosomes in the GnomAD database, including 211 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).

Frequency

Genomes: 𝑓 0.051 ( 210 hom., cov: 32)
Exomes 𝑓: 0.026 ( 1 hom. )

Consequence

ABCB1
NM_001348946.2 5_prime_UTR

Scores

2

Clinical Significance

drug response no assertion criteria provided O:1

Conservation

PhyloP100: 0.417

Publications

151 publications found
Variant links:
Genes affected
ABCB1 (HGNC:40): (ATP binding cassette subfamily B member 1) The membrane-associated protein encoded by this gene is a member of the superfamily of ATP-binding cassette (ABC) transporters. ABC proteins transport various molecules across extra- and intra-cellular membranes. ABC genes are divided into seven distinct subfamilies (ABC1, MDR/TAP, MRP, ALD, OABP, GCN20, White). This protein is a member of the MDR/TAP subfamily. Members of the MDR/TAP subfamily are involved in multidrug resistance. The protein encoded by this gene is an ATP-dependent drug efflux pump for xenobiotic compounds with broad substrate specificity. It is responsible for decreased drug accumulation in multidrug-resistant cells and often mediates the development of resistance to anticancer drugs. This protein also functions as a transporter in the blood-brain barrier. Mutations in this gene are associated with colchicine resistance and Inflammatory bowel disease 13. Alternative splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, Feb 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.8).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0827 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ABCB1NM_001348946.2 linkc.-129T>C 5_prime_UTR_variant Exon 1 of 28 ENST00000622132.5 NP_001335875.1
ABCB1NM_000927.5 linkc.-129T>C 5_prime_UTR_variant Exon 2 of 29 NP_000918.2
ABCB1NM_001348945.2 linkc.134-52T>C intron_variant Intron 4 of 31 NP_001335874.1
ABCB1NM_001348944.2 linkc.-77-52T>C intron_variant Intron 2 of 29 NP_001335873.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ABCB1ENST00000622132.5 linkc.-129T>C 5_prime_UTR_variant Exon 1 of 28 1 NM_001348946.2 ENSP00000478255.1

Frequencies

GnomAD3 genomes
AF:
0.0509
AC:
7747
AN:
152082
Hom.:
205
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0846
Gnomad AMI
AF:
0.00768
Gnomad AMR
AF:
0.0335
Gnomad ASJ
AF:
0.0219
Gnomad EAS
AF:
0.0502
Gnomad SAS
AF:
0.0338
Gnomad FIN
AF:
0.0341
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0401
Gnomad OTH
AF:
0.0569
GnomAD4 exome
AF:
0.0261
AC:
6
AN:
230
Hom.:
1
Cov.:
0
AF XY:
0.0154
AC XY:
2
AN XY:
130
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.00
AC:
0
AN:
20
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AF:
0.00
AC:
0
AN:
14
European-Finnish (FIN)
AC:
0
AN:
0
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
2
European-Non Finnish (NFE)
AF:
0.0319
AC:
6
AN:
188
Other (OTH)
AF:
0.00
AC:
0
AN:
4
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.550
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.0511
AC:
7779
AN:
152200
Hom.:
210
Cov.:
32
AF XY:
0.0499
AC XY:
3711
AN XY:
74410
show subpopulations
African (AFR)
AF:
0.0851
AC:
3534
AN:
41538
American (AMR)
AF:
0.0334
AC:
511
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.0219
AC:
76
AN:
3466
East Asian (EAS)
AF:
0.0503
AC:
259
AN:
5152
South Asian (SAS)
AF:
0.0340
AC:
164
AN:
4818
European-Finnish (FIN)
AF:
0.0341
AC:
362
AN:
10612
Middle Eastern (MID)
AF:
0.0510
AC:
15
AN:
294
European-Non Finnish (NFE)
AF:
0.0401
AC:
2730
AN:
68008
Other (OTH)
AF:
0.0572
AC:
121
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.511
Heterozygous variant carriers
0
385
770
1156
1541
1926
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0438
Hom.:
470
Bravo
AF:
0.0514
Asia WGS
AF:
0.0430
AC:
151
AN:
3478

ClinVar

Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Tramadol response Other:1
Apr 28, 2018
Bruce Budowle Laboratory, University of North Texas Health Science Center
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:research

- T:M1 = postmortem ratio or tramadol to O-desmethyltramadol; t-MP = model-based clustered metabolizer phenotype inferred from T:M1

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.80
CADD
Benign
8.3
DANN
Benign
0.35
PhyloP100
0.42
PromoterAI
0.13
Neutral
Mutation Taster
=300/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3213619; hg19: chr7-87230193; API